Björn Hackanson

3.1k total citations
51 papers, 1.7k citations indexed

About

Björn Hackanson is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Björn Hackanson has authored 51 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 27 papers in Hematology and 13 papers in Oncology. Recurrent topics in Björn Hackanson's work include Acute Myeloid Leukemia Research (25 papers), Epigenetics and DNA Methylation (23 papers) and Histone Deacetylase Inhibitors Research (11 papers). Björn Hackanson is often cited by papers focused on Acute Myeloid Leukemia Research (25 papers), Epigenetics and DNA Methylation (23 papers) and Histone Deacetylase Inhibitors Research (11 papers). Björn Hackanson collaborates with scholars based in Germany, United States and France. Björn Hackanson's co-authors include Michael Lübbert, Manfred Jung, Julia M. Wagner, Christoph Plass, Michael Daskalakis, Rainer Claus, Romulo Martin Brena, Claudia Schmoor, Konstanze Döhner and Cora Mund and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Blood.

In The Last Decade

Björn Hackanson

50 papers receiving 1.7k citations

Peers

Countries citing papers authored by Björn Hackanson

Since Specialization

Citations

This map shows the geographic impact of Björn Hackanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Hackanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Hackanson more than expected).

Fields of papers citing papers by Björn Hackanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Hackanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Hackanson. The network helps show where Björn Hackanson may publish in the future.

Co-authorship network of co-authors of Björn Hackanson

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Hackanson. A scholar is included among the top collaborators of Björn Hackanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Hackanson. Björn Hackanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Alterations in Peripheral Lymphocyte Subsets under Immunochemotherapy in Stage IV SCLC Patients: Th17 Cells as Potential Early Predictive Biomarker for Response 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Maik Konrad, (unknown), (unknown), Stefan Schiele, (unknown), Björn Hackanson, Andreas Rank	3
2	In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts 2023 ·Leukemia ·Gabriele Greve, Geoffroy Andrieux, Pascal Schlosser, Nadja Blagitko‐Dorfs, (unknown), (unknown), Dietmar Pfeifer, (unknown), Andreas Neubauer, Jürgen Krauter, Michael Heuser, Helmut R. Salih, Konstanze Döhner, Hartmut Döhner, Björn Hackanson, Melanie Boerries, Michael Lübbert	2
3	First‐linenab‐paclitaxel plus carboplatin for patients with advanced non‐small cell lung cancer: Final results of the NEPTUN study 2023 ·International Journal of Cancer ·Tobias Dechow, Jorge Riera‐Knorrenschild, Björn Hackanson, Jan Janßen, Holger Schulz, (unknown), Marco Chiabudini, Ludwig Fischer von Weikersthal, Stephan Budweiser, (unknown), (unknown), Manfred Welslau, Karin Potthoff	2
4	Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia 2020 ·Annals of Hematology ·Heiko Becker, Dietmar Pfeifer, Gabriele Ihorst, Milena Pantić, Julius Wehrle, Björn Rüter, Lars Bullinger, Björn Hackanson, Ulrich Germing, Andrea Kuendgen, Uwe Platzbecker, Konstanze Döhner, Arnold Ganser, Anne Hagemeijer, Pierre W. Wijermans, Hartmut Döhner, Justus Duyster, Michael Lübbert	11
5	533MO Phase Ib study of BI 836880, a VEGF/Ang2-blocking nanobody®, in combination with BI 754091, an anti-PD-1 antibody: Initial results in patients (pts) with solid tumours 2020 ·Annals of Oncology ·N. Girard, Martin Wermke, Fabrice Barlési, Dongwook Kim, François Ghiringhelli, (unknown), (unknown), (unknown), Björn Hackanson	2
6	Evaluating the impact of genetic and epigenetic aberrations on survival and response in acute myeloid leukemia patients receiving epigenetic therapy 2017 ·Annals of Hematology ·(unknown), Claudia Schmoor, Verena I. Gaidzik, (unknown), (unknown), (unknown), Nadja Blagitko‐Dorfs, Konstanze Döhner, Lars Bullinger, Justus Duyster, Michael Lübbert, Björn Hackanson	19
7	Molecular Genetic Characterization of Individual Cancer Cells Isolated via Single-Cell Printing 2016 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), Dietmar Pfeifer, (unknown), Klaus H. Metzeler, Björn Hackanson, Michael Lübbert, Justus Duyster, Peter Koltay, Roland Zengerle, Rainer Claus, Stefan Zimmermann, Heiko Becker	15
8	Decitabine 2014 ·Recent results in cancer research ·Björn Hackanson, Michael Daskalakis	42
9	MeDIP coupled with a promoter tiling array as a platform to investigate global DNA methylation patterns in AML cells 2012 ·Leukemia Research ·(unknown), Clemens Kreutz, Dietmar Pfeifer, (unknown), (unknown), Jens Timmer, Michael Lübbert, Björn Hackanson	12
10	Epigenetische Modifikationen in malignen Zellen 2011 ·DMW - Deutsche Medizinische Wochenschrift ·Björn Hackanson, Michael Lübbert	1
11	A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy 2011 ·Haematologica ·Michael Lübbert, Björn Rüter, Rainer Claus, Claudia Schmoor, Mathias Schmid, Ulrich Germing, Andrea Kuendgen, Volker Rethwisch, Arnold Ganser, Uwe Platzbecker, Oliver Galm, Wolfram Brugger, Gerhard Heil, Björn Hackanson, Barbara Deschler-Baier, Konstanze Döhner, A Hagemeijer, P. Wijermans, Hartmut Döhner	172
12	Long-term follow-up of patients with chronic myeloid leukemia having received autologous stem cell transplantation 2010 ·Annals of Hematology ·Björn Hackanson, Cornelius F. Waller	6
13	Decitabine 2009 ·Recent results in cancer research ·Michael Daskalakis, Nadja Blagitko‐Dorfs, Björn Hackanson	37
14	Epigenetic Modification of CCAAT/Enhancer Binding Protein α Expression in Acute Myeloid Leukemia 2008 ·Cancer Research ·Björn Hackanson, Kristi L. Bennett, Romulo Martin Brena, Jinmai Jiang, Rainer Claus, Shih-Shih Chen, (unknown), (unknown), Susan P. Whitman, Thomas D. Schmittgen, Michael Lübbert, Guido Marcucci, Clara D. Bloomfield, Christoph Plass	114
15	DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication 2008 ·Blood ·Susan P. Whitman, Björn Hackanson, Sandya Liyanarachchi, Shujun Liu, Laura J. Rush, Kati Maharry, Dean Margeson, Ramana V. Davuluri, Jing Wen, (unknown), Li Yu, Chunhui Liu, Clara D. Bloomfield, Guido Marcucci, Christoph Plass, Michael A. Caligiuri	56
16	Tumor Suppressor Activity of CCAAT/Enhancer Binding Protein α Is Epigenetically Down-regulated in Head and Neck Squamous Cell Carcinoma 2007 ·Cancer Research ·Kristi L. Bennett, Björn Hackanson, Laura T. Smith, Quaid Morris, James C. Lang, David E. Schuller, Frank Weber, Charis Eng, Christoph Plass	74
17	Updated results of a phase I study of low dose decitabine and valproic acid (VA) in patients with acute myeloid leukemia (AML): Gene reexpression, demethylation, and clinical response 2006 ·Journal of Clinical Oncology ·Rebecca B. Klisovic, William Blum, Björn Hackanson, Cheryl Kefauver, (unknown), Zhengyu Liu, Karen K. L. Chan, Christoph Plass, Michael R. Grever, John C. Byrd, Guido Marcucci	1
18	The silence of the genes: epigenetic disturbances in haematopoietic malignancies 2005 ·Expert Opinion on Therapeutic Targets ·Björn Hackanson, Yalin Guo, Michael Lübbert	11
19	Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1 2005 ·Nature Genetics ·Frank Rosenbauer, Bronwyn M. Owens, Li Yu, Joseph R. Tumang, Ulrich Steidl, Jeffery L. Kutok, Linda K. Clayton, Katharina Wagner, Marina Scheller, Hiromi Iwasaki, Chunhui Liu, Björn Hackanson, Koichi Akashi, Achim Leutz, Thomas L. Rothstein, Christoph Plass, Daniel G. Tenen	169
20	Unusual Cases in Multiple Myeloma and a Dramatic Response in Metastatic Lung Cancer 2004 ·Journal of Clinical Oncology ·Robert Zeiser, Björn Hackanson, Thorsten Alexander Bley, Jürgen Finke, Hartmut Bertz	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact